Opening Keynote Presentation

GOLD Neonatal is pleased to offer this free Keynote Presentation open to the general public.

We're thrilled to have Dr. Terri Marin, PhD, NNP-BC, FAAN, FAANP as one of our 2022 Keynote Speakers. Dr. Terri's presentation, "Physiologic Biomarkers to Detect Subclinical Acute Kidney Injury in Premature Infants", will kick off our Sixth Annual Neonatal Conference on May 31. We invite you to join us at one or both of our live sessions or access the public recording of this talk until June 30. Simply reserve your seat to receive exclusive access. A Certificate of Attendance will be provided.

Need Continuing Education Credits? Only attendees registered for the full conference will be able to claim continuing education hours and can do so by logging in to the Delegates Area prior to watching the presentation. To learn more about registering for the conference, please visit this page. Registered Conference Participants will have access to this presentation and 13 additional presentations until August 23, 2022 (Annual Members will have until September 13, 2022).

Please invite your friends and keep the discussion going after the talks take place. Tag & share through these social media posts: Facebook | Twitter | Instagram | LinkedIn

*Important* - If you are a Registered Conference Participant, please log in and view the presentation through the Lobby or Recording page in the Delegates Area in order to be eligible for your CERP/Nurse Contact Hour/CME/CEU credits.

Reserve Your Free Seat!

Sign up today to receive access for this Keynote Webinar.

Live Presentation Time

May 31, 2022 16:00 UTC
or 22:00 UTC

  • Submit

preterm-speakersKeynote Speaker & Presentation Info

Terri Marin, PhD, NNP-BC, FAAN, FAANP

Dr. Marin is currently an Assistant Professor at Augusta University, and is an active researcher in the Level IV NICU at Children’s Hospital of Georgia. She received her BSN from the University of Tennessee, her MSN from Stony Brook and her PhD from Emory University. Dr. Marin’s program of research is focused on defining non-invasive methods to predict early-onset acute kidney injury in preterm infants, including analysis of metabolomics, proteomics, the gut-kidney microbiome axis, and renal hypoxia measured by near-infrared spectroscopy as they relate to subclinical and actual acute kidney disease.

Abstract: Physiologic Biomarkers to Detect Subclinical Acute Kidney Injury in Premature Infants

Acute kidney Injury (AKI) prior to the completion of nephrogenesis at 34 weeks’ gestation has significant life-long effects. The immature kidney only receives 3-4% of total cardiac output, compared to 20% in term infants, children and adults. Therefore, minimal decreases in oxygen delivery may substantially compromise proper oxygen utilization increasing the risk for morphologic changes and reduced nephron endowment. Current diagnostic criteria (serum creatinine (sCr) elevations with oliguria) cannot detect early-onset AKI, as up to 50% of nephron damage has already occurred by the time these abnormalities become apparent. This presentation will look at new research related to the current diagnostic criteria for AKI in the preterm infant, the physiologic mechanisms involved in AKI and short and long-term implications.

Share This Presentation Online Stay in touch, Like us on Facebook

preterm-detail-iconAdditional Information

CME/Nurse Contact Hour/CERP Certificates:

*Free access to the general public is available live on May 31 and as a recording on our website until June 30, 2022. A Certificate of Attendance will be available for attendees.

*Only registered participants will be awarded Educational Credit for this presentation and are required to view the live presentation/recording through the Delegates Dashboard to be able to confirm attendace.

*Please be aware that the Handouts to this presentation are for use only by individuals who have attended the live or recorded version of this presentation; and that they are for personal use only and are not to be shared with other non-attending individuals. Thank you.